|
ZXDB expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.160000E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.816000E-01 |
| Normal-vs-Stage2 |
2.050100E-02 |
| Normal-vs-Stage3 |
1.91000000004937E-06 |
| Normal-vs-Stage4 |
2.51799999961833E-07 |
| Stage1-vs-Stage2 |
8.269600E-02 |
| Stage1-vs-Stage3 |
6.06089999999337E-05 |
| Stage1-vs-Stage4 |
2.72850000004876E-06 |
| Stage2-vs-Stage3 |
2.439200E-01 |
| Stage2-vs-Stage4 |
1.045780E-01 |
| Stage3-vs-Stage4 |
5.726000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.985600E-04 |
| Normal-vs-AfricanAmerican |
1.536670E-03 |
| Normal-vs-Asian |
7.746400E-01 |
| Caucasian-vs-AfricanAmerican |
2.848600E-01 |
| Caucasian-vs-Asian |
6.087400E-01 |
| AfricanAmerican-vs-Asian |
3.465400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.169500E-04 |
| Normal-vs-Female |
1.661630E-02 |
| Male-vs-Female |
2.621600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.110100E-02 |
| Normal-vs-Age(41-60Yrs) |
9.096900E-03 |
| Normal-vs-Age(61-80Yrs) |
6.646400E-04 |
| Normal-vs-Age(81-100Yrs) |
4.220400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.544200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.833400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.780000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.823800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.633400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.802000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.005200E-01 |
| Normal-vs-Grade 2 |
3.163000E-01 |
| Normal-vs-Grade 3 |
3.94650000000718E-05 |
| Normal-vs-Grade 4 |
1.89270044081979E-10 |
| Grade 1-vs-Grade 2 |
2.119200E-01 |
| Grade 1-vs-Grade 3 |
1.001690E-02 |
| Grade 1-vs-Grade 4 |
1.55491999999091E-05 |
| Grade 2-vs-Grade 3 |
7.639700E-04 |
| Grade 2-vs-Grade 4 |
2.55779997182515E-09 |
| Grade 3-vs-Grade 4 |
1.180290E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.664200E-01 |
| Normal-vs-ccB subtype |
2.011000E-04 |
| ccA subtype-vs-ccB subtype |
1.361670E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.447200E-04 |
| Normal-vs-N1 |
3.811200E-04 |
| N0-vs-N1 |
1.697590E-01 |
|
|
